Sarcoidosis-associated fibrosing mediastinitis with resultant pulmonary hypertension: A case report and review of the literature

Respiration

Volumn 79, Issue 4, 2010, Pages 341-345

  Toonkel, Rebecca L ^a   Borczuk, Alain C ^a   Pearson, Gregory D ^a   Horn, Evelyn M ^a   Thomashow, Byron M ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b NONE   (United States)

Author keywords

Hypertension, pulmonary; Mediastinitis, fibrosing; Sarcoidosis

Indexed keywords

PREDNISONE;

ADULT; ARTICLE; CASE REPORT; COUGHING; DYSPNEA; HEART CATHETERIZATION; HISTOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LUNG ARTERY PRESSURE; LUNG SARCOIDOSIS; MALE; MEDIASTINITIS; MEDIASTINOSCOPY; MEDIASTINUM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION;

HUMANS; HYPERTENSION, PULMONARY; MALE; MEDIASTINITIS; MIDDLE AGED; SARCOIDOSIS, PULMONARY;

EID: 77949262354     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000243786     Document Type: Article

References (28)

1. Gluskowski J, Hawrylkiewicz I, Zych D, Wojtczak A, Zielinski J: Pulmonary haemodynamics at rest and during exercise in patients with sarcoidosis. Respiration 1984;46:26-32.
2. Gluskowski J, Hawrylkiewicz I, Zych D, Zielinski J: Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis. Eur Respir J 1990;3:403-407.
3. Handa T, Nagai S, Miki S, Fushimi Y, Ohta K, Mishima M, et al: Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006;129:1246-1252.
4. Mitchell DN, Scadding JG: Sarcoidosis. Am Rev Respir Dis 1974;110:774-802.
5. Rizzato G, Pezzano A, Sala G, Merlini R, Ladelli L, Tansini G, et al: Right heart impairmentin sarcoidosis: haemodynamic and echocardiographic study. Eur J Respir Dis 1983;64:121-128.
6. Shorr AF, Helman DL, Davies DB, Nathan SD: Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005;25:783-788.
7. Nunes H, Humbert M, Capron F, Brauner M, Sitbon O, Battesti JP, et al: Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006;61:68-74.
8. Damuth TE, Bower JS, Cho K, Dantzker DR: Major pulmonary artery stenosis causing pulmonary hypertension in sarcoidosis. Chest 1980;78:888-891.
9. Levine BW, Saldana M, Hutter AM: Pulmonary hypertension in sarcoidosis. A case report of a rare but potentially treatable cause. Am Rev Respir Dis 1971;103:413-417.
10. Shorr AF, Davies DB, Nathan SD: Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 2003;124:922-928.
11. Davies J, Nellen M, Goodwin JF: Reversible pulmonary hypertension in sarcoidosis. Postgrad Med J 1982;58:282-285.
12. Hoffstein V, Ranganathan N, Mullen JB: Sarcoidosis simulating pulmonary veno-occlusive disease. Am Rev Respir Dis 1986;134:809-811.
13. Smith LJ, Lawrence JB, Katzenstein AA: Vascular sarcoidosis: a rare cause of pulmonary hypertension. Am J Med Sci 1983;285:38-44.
14. Battesti JP, Georges R, Basset F, Saumon G: Chronic cor pulmonale in pulmonary sarcoidosis. Thorax 1978;33:76-84.
15. Arcasoy SM, Christie JD, Pochettino A, Rosengard BR, Blumenthal NP, Bavaria JE, et al: Characteristics and outcomes of patients with sarcoidosis listed for lung trans-plantation. Chest 2001;120:873-880.
16. Tayal S, Voelkel NF, Rai PR, Cool CD: Sarcoidois and pulmonary hypertension - a case report. Eur J Med Res 2006;11:194-197.
17. Portier F, Lerebours-Pigeonniere G, Thiberville L, Dominique S, Tayot J, Muir JF, et al: Sarcoidosis simulating a pulmonary veno-occlusive disease (in French). Rev Mal Respir 1991;8:101-102.
18. Salazar A, Mana J, Sala J, Landoni BR, Manresa F: Combined portal and pulmonary hypertension in sarcoidosis. Respiration 1994;61:117-119.
19. Cornet A, Barbier JP, Debesse B, Even P, Carnot F, Neveu D: Sarcoidosis and portal and pulmonary arterial hypertension: a case report (author's transl) (in French). Ann Med Interne (Paris) 1980;131:431-434.
20. Barst RJ, Ratner SJ: Sarcoidosis and reactive pulmonary hypertension. Arch Intern Med 1985;145:2112-2114.
21. Sulica R, Teirstein AS, Kakarla S, Nemani N, Behnegar A, Padilla ML: Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hy per tension. Chest 2005;128:1483-1489.
22. Emirgil C, Sobol BJ, Herbert WH, Trout K: The lesser circulation in pulmonary fibrosis secondary to sarcoidosis and its relationship to respiratory function. Chest 1971;60:371-378.
23. Fisher KA, Serlin DM, Wilson KC, Walter RE, Berman JS, Farber HW: Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment. Chest 2006;130:1481-1488.
24. Shorr AF, Davies DB, Nathan SD: Outcomes for patients with sarcoidosis awaiting lung transpla ntation. Chest 2002;122:233-238.
25. Preston IR, Klinger JR, Landzberg MJ, Houtchens J, Nelson D, Hill NS: Vasorespon-siveness of sarcoidosis-associated pulmonary hypertension. Chest 2001;120:866-872.
26. Milman N, Burton CM, Iversen M, Videbaek R, Jensen CV, Carlsen J: Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil? J Heart Lung Transplant 2008;27:329-334.
27. Foley RJ, Metersky ML: Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan. Respiration 2008;75:211-214.
28. Rodman DM, Lindenfeld J: Successful treatment of sarcoidosis-associated pulmonary hypertension with corticosteroids. Chest 1990;97:500-502.